Similar articles

• Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study.

  Loew TH, Nickel MK, Muehlbacher M, Kaplan P, Nickel C, Kettler C, Fartacek R, Lahmann C, Buschmann W, Tritt K, Bachler E, Mitterlehner F, Pedrosa Gil F, Leiberich P, Rother WK, Egger C. Loew TH, et al. J Clin Psychopharmacol. 2006 Feb;26(1):61-6. doi: 10.1097/01.jcp.0000195113.61291.48. J Clin Psychopharmacol. 2006. PMID: 16415708 Clinical Trial.
• Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study.

  Nickel MK, Nickel C, Mitterlehner FO, Tritt K, Lahmann C, Leiberich PK, Rother WK, Loew TH. Nickel MK, et al. J Clin Psychiatry. 2004 Nov;65(11):1515-9. doi: 10.4088/jcp.v65n1112. J Clin Psychiatry. 2004. PMID: 15554765 Clinical Trial.
• Shame and implicit self-concept in women with borderline personality disorder.

  Rüsch N, Lieb K, Göttler I, Hermann C, Schramm E, Richter H, Jacob GA, Corrigan PW, Bohus M. Rüsch N, et al. Am J Psychiatry. 2007 Mar;164(3):500-8. doi: 10.1176/ajp.2007.164.3.500. Am J Psychiatry. 2007. PMID: 17329476
• [Mood stabilizer in the psychopharmacotherapy of borderline personality disorder].

  Gescher DM, Malevani J. Gescher DM, et al. Fortschr Neurol Psychiatr. 2009 Jul;77(7):389-98. doi: 10.1055/s-0028-1109455. Epub 2009 May 19. Fortschr Neurol Psychiatr. 2009. PMID: 19455483 Review. German.
• [Symptom-focussed drug therapy in borderline personality disorder].

  Schmahl C, Bohus M. Schmahl C, et al. Fortschr Neurol Psychiatr. 2001 Jul;69(7):310-21. doi: 10.1055/s-2001-15305. Fortschr Neurol Psychiatr. 2001. PMID: 11488246 Review. German.